BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
QuintilesIMS
Dow
Daiichi Sankyo
Healthtrust
AstraZeneca
Deloitte
McKinsey
Julphar

Generated: January 19, 2018

DrugPatentWatch Database Preview

Aqua Pharms Company Profile

« Back to Dashboard

Summary for Aqua Pharms
International Patents:147
US Patents:12
Tradenames:11
Ingredients:9
NDAs:11

Drugs and US Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms Llc ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aqua Pharms XOLEGEL ketoconazole GEL;TOPICAL 021946-001 Jul 28, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms ACTICLATE CAP doxycycline hyclate CAPSULE;ORAL 208253-001 Apr 26, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aqua Pharms XOLEGEL ketoconazole GEL;TOPICAL 021946-001 Jul 28, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms MONODOX doxycycline CAPSULE;ORAL 050641-003 Oct 18, 2006 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aqua Pharms Llc ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aqua Pharms FLUOROPLEX fluorouracil CREAM;TOPICAL 016988-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 ➤ Subscribe ➤ Subscribe
Aqua Pharms SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 ➤ Subscribe ➤ Subscribe
Aqua Pharms Llc VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Aqua Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,263,580 Vitamin formulation ➤ Subscribe
RE39128 Pleuromutilin derivatives as antimicrobials ➤ Subscribe
6,281,226 Pleuromutilin derivatives as antimicrobials ➤ Subscribe
8,298,515 Vitamin formulation ➤ Subscribe
8,629,128 Vitamin formulation ➤ Subscribe
6,238,683 Anhydrous topical skin preparations ➤ Subscribe
8,449,867 Microemulsion and sub-micron emulsion process and compositions ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Aqua Pharms Drugs

Country Document Number Estimated Expiration
Japan 2002524490 ➤ Subscribe
Spain 2299258 ➤ Subscribe
Poland 340254 ➤ Subscribe
China 101048136 ➤ Subscribe
Brazil 0113460 ➤ Subscribe
Austria 318148 ➤ Subscribe
Poland 365681 ➤ Subscribe
China 1292707 ➤ Subscribe
Portugal 1028961 ➤ Subscribe
Norway 20091344 ➤ Subscribe
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Aqua Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1028961/01 Switzerland ➤ Subscribe PRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009
2013 00053 Denmark ➤ Subscribe PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
00617 Netherlands ➤ Subscribe PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
13/044 Ireland ➤ Subscribe PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992/01 Switzerland ➤ Subscribe PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
2013025,C1304992 Lithuania ➤ Subscribe PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
372 Luxembourg ➤ Subscribe 91372, EXPIRES: 20220524
6 Finland ➤ Subscribe
C0057 France ➤ Subscribe PRODUCT NAME: RETAPAMULIN; REGISTRATION NO/DATE IN FRANCE: EU/1/07/390/001 DU 20070524; REGISTRATION NO/DATE AT EEC: EU/1/07/390/001 DU 20070524
C/GB07/061 United Kingdom ➤ Subscribe PRODUCT NAME: RETAPAMULIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/390/001 20070524; UK EU/1/07/390/002 20070524; UK EU/1/07/390/003 20070524; UK EU/1/07/390/004 20070524
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Accenture
QuintilesIMS
Express Scripts
Citi
Cipla
US Department of Justice
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot